Drug Delivery Devices Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Drug Delivery Devices Market, By Route of Administration

7.1.  Drug Delivery Devices Market, By Route of Administration Type, 2020-2027

7.1.1.    Oral

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Inhalation

7.1.2.1.        Market Revenue and Forecast (2016-2027)

7.1.3.    Transdermal

7.1.3.1.        Market Revenue and Forecast (2016-2027)

7.1.4.    Injectable

7.1.4.1.        Market Revenue and Forecast (2016-2027)

7.1.5.    Ocular

7.1.5.1.        Market Revenue and Forecast (2016-2027) )

7.1.6.    Nasal

7.1.6.1.        Market Revenue and Forecast (2016-2027) )

7.1.7.    Topical

7.1.7.1.        Market Revenue and Forecast (2016-2027)

7.1.8.    Others

7.1.8.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global Drug Delivery Devices Market, By Vehicles

8.1.  Drug Delivery Devices Market, By Vehicles, 2020-2027

8.1.1.    Oncology

8.1.1.1.        Market Revenue and Forecast (2016-2027)

8.1.2.    Infectious Diseases

8.1.2.1.        Market Revenue and Forecast (2016-2027)

8.1.3.    Respiratory Diseases

8.1.3.1.        Market Revenue and Forecast (2016-2027)

8.1.4.    Diabetes

8.1.4.1.        Market Revenue and Forecast (2016-2027)  

8.1.5.    Cardiovascular Diseases

8.1.5.1.        Market Revenue and Forecast (2016-2027)

8.1.6.    Autoimmune Diseases

8.1.6.1.        Market Revenue and Forecast (2016-2027)

8.1.7.    Central Nervous System Disorders

8.1.7.1.        Market Revenue and Forecast (2016-2027)

8.1.8.    Others

8.1.8.1.        Market Revenue and Forecast (2016-2027)

Chapter 9.  Global Drug Delivery Devices Market, By Vehicles

9.1.  Drug Delivery Devices Market, By Vehicles, 2020-2027

9.1.1.    Hospitals

9.1.1.1.        Market Revenue and Forecast (2016-2027)

9.1.2.    Diagnostic Centers

9.1.2.1.        Market Revenue and Forecast (2016-2027)

9.1.3.    Ambulatory Surgery Centers/Clinics

9.1.3.1.        Market Revenue and Forecast (2016-2027)

9.1.4.    Home Care Settings

9.1.4.1.        Market Revenue and Forecast (2016-2027)

9.1.5.    Other

9.1.5.1.        Market Revenue and Forecast (2016-2027)

Chapter 10.      Global Drug Delivery Devices Market, By Vehicles

10.1.        Drug Delivery Devices Market, By Vehicles, 2020-2027

10.1.1.  Hydrogel

10.1.1.1.      Market Revenue and Forecast (2016-2027)

10.1.2.  Micelle

10.1.2.1.      Market Revenue and Forecast (2016-2027)

10.1.3.  Dendrimer

10.1.3.1.      Market Revenue and Forecast (2016-2027)

10.1.4.  Nanoparticle

10.1.4.1.      Market Revenue and Forecast (2016-2027)

10.1.5.  Liposome

10.1.5.1.      Market Revenue and Forecast (2016-2027)

10.1.6.  Scaffold

10.1.6.1.      Market Revenue and Forecast (2016-2027)

10.1.7.  Mesoporous Material

10.1.7.1.      Market Revenue and Forecast (2016-2027)

10.1.8.  Niosomes

10.1.8.1.      Market Revenue and Forecast (2016-2027)

Chapter 11.      Global Drug Delivery Devices Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, By Route of Administration (2016-2027)

11.1.2.  Market Revenue and Forecast, By Vehicles (2016-2027)

11.1.3.  Market Revenue and Forecast, By Vehicles (2016-2027)

11.1.4.  Market Revenue and Forecast, By Vehicles (2016-2027)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, By Route of Administration (2016-2027)

11.1.5.2.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.1.5.3.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.1.5.4.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, By Route of Administration (2016-2027)

11.1.6.2.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.1.6.3.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.1.6.4.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, By Route of Administration (2016-2027)

11.2.2.  Market Revenue and Forecast, By Vehicles (2016-2027)

11.2.3.  Market Revenue and Forecast, By Vehicles (2016-2027)

11.2.4.  Market Revenue and Forecast, By Vehicles (2016-2027)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, By Route of Administration (2016-2027)

11.2.5.2.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.2.5.3.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.2.5.4.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, By Route of Administration (2016-2027)

11.2.6.2.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.2.6.3.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.2.6.4.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, By Route of Administration (2016-2027)

11.2.7.2.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.2.7.3.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.2.7.4.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, By Route of Administration (2016-2027)

11.2.8.2.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.2.8.3.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.2.8.4.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, By Route of Administration (2016-2027)

11.3.2.  Market Revenue and Forecast, By Vehicles (2016-2027)

11.3.3.  Market Revenue and Forecast, By Vehicles (2016-2027)

11.3.4.  Market Revenue and Forecast, By Vehicles (2016-2027)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, By Route of Administration (2016-2027)

11.3.5.2.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.3.5.3.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.3.5.4.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, By Route of Administration (2016-2027)

11.3.6.2.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.3.6.3.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.3.6.4.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, By Route of Administration (2016-2027)

11.3.7.2.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.3.7.3.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.3.7.4.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, By Route of Administration (2016-2027)

11.3.8.2.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.3.8.3.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.3.8.4.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, By Route of Administration (2016-2027)

11.4.2.  Market Revenue and Forecast, By Vehicles (2016-2027)

11.4.3.  Market Revenue and Forecast, By Vehicles (2016-2027)

11.4.4.  Market Revenue and Forecast, By Vehicles (2016-2027)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, By Route of Administration (2016-2027)

11.4.5.2.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.4.5.3.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.4.5.4.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, By Route of Administration (2016-2027)

11.4.6.2.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.4.6.3.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.4.6.4.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, By Route of Administration (2016-2027)

11.4.7.2.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.4.7.3.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.4.7.4.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, By Route of Administration (2016-2027)

11.4.8.2.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.4.8.3.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.4.8.4.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, By Route of Administration (2016-2027)

11.5.2.  Market Revenue and Forecast, By Vehicles (2016-2027)

11.5.3.  Market Revenue and Forecast, By Vehicles (2016-2027)

11.5.4.  Market Revenue and Forecast, By Vehicles (2016-2027)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, By Route of Administration (2016-2027)

11.5.5.2.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.5.5.3.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.5.5.4.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, By Route of Administration (2016-2027)

11.5.6.2.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.5.6.3.      Market Revenue and Forecast, By Vehicles (2016-2027)

11.5.6.4.      Market Revenue and Forecast, By Vehicles (2016-2027)

Chapter 12.  Company Profiles

12.1.              Pfizer, Inc

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Johnson & Johnson Services, Inc.

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              F. Hoffmann-La Roche, Ltd

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Novartis AG; BD

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Bayer AG.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              uniQure N.V

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Sibiono GeneTech Co. Ltd.

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms